Feasibility Trial of Carotid Stenting with and without an Embolus Protection Device

Purpose: To evaluate the feasibility of stenting and cerebral protection in patients with carotid bifurcation disease. Methods: Carotid stenting with self-expanding nitinol stents was evaluated in 261 patients (157 men; mean age 70.9±9.7 years, range 41–90) treated at 33 clinical sites. Among these patients, 141 (54.3%) were symptomatic, and 71 (27.2%) had postendarterectomy restenotic lesions. An embolus protection device became available in the latter third of the study. The primary endpoint of the study was the 30-day composite occurrence of major adverse clinical events (all deaths, strokes, or myocardial infarctions [MI]). At 1 year, the endpoint included all deaths, strokes, or MIs at 30 days, plus all deaths or ipsilateral strokes between 31 days and 1 year. Results: SMART stents were placed in 147 (56%) patients and Precise stents in 107 (41%); 7 (3%) patients were treated with non-study stents. Lesion success, defined as < 30% postprocedural residual stenosis, was achieved in 249 (95%). An AngioGuard filter was used in 85 patients; of 90 filters employed, 78 (87%) were successfully deployed and retrieved. Visible material was noted in 42 (54%) retrieved filters. One (0.4%) stent thrombosis occurred at < 30 days, and no restenotic lesions >80% were noted in up to 1 year of follow-up. At 30 days, stroke occurred in 16 (6.1%) patients, MI in 1 (0.4%), and 2 (0.8%) patients died. The 30-day rate of stroke, MI, or death was 6.9%. Major ipsilateral stroke occurred in 4 (1.5%) patients between 0 and 30 days; no new major ipsilateral strokes were noted up to 1 year. By Kaplan-Meier analysis, the 1-year risk of stroke. Conclusions: The use of nitinol self-expanding stents in the carotid position appears to be a safe and efficacious alternative for the treatment of carotid bifurcation disease. The addition of embolus protection devices may diminish the risk of postprocedural major ipsilateral strokes. MI, or death was 10.9%±2.0%. The 1-year risk of major ipsilateral stroke was significantly lower in patients treated with embolus protection devices (0.0% versus 2.3%, p=0.05).

[1]  T. Hölzenbein,et al.  Protected carotid-artery stenting versus endarterectomy in high-risk patients , 2005, European Surgery.

[2]  R. Hobson.  Rationale and status of randomized controlled clinical trials in carotid artery stenting. , 2003, Seminars in vascular surgery.

[3]  Mark H Wholey,et al.  Updated review of the global carotid artery stent registry , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4]  F. Veith,et al.  Initial experience with cerebral protection devices to prevent embolization during carotid artery stenting. , 2002, Journal of vascular surgery.

[5]  A. Angelini,et al.  Cerebral Protection During Carotid Artery Stenting: Collection and Histopathologic Analysis of Embolized Debris , 2002, Stroke.

[6]  M. Bates,et al.  Cerebral protection systems for distal emboli during carotid artery interventions. , 2001, Journal of interventional cardiology.

[7]  K. Ouriel,et al.  Preprocedural risk stratification: identifying an appropriate population for carotid stenting. , 2001, Journal of vascular surgery.

[8]  D. Nilasena,et al.  Multistate utilization, processes, and outcomes of carotid endarterectomy. , 2001, Journal of vascular surgery.

[9]  D. Rüfenacht,et al.  Role of the Distal Balloon Protection Technique in the Prevention of Cerebral Embolic Events During Carotid Stent Placement , 2001, Stroke.

[10]  A. AbuRahma,et al.  Cranial and cervical nerve injuries after repeat carotid endarterectomy. , 2000, Journal of vascular surgery.

[11]  V. Hachinski,et al.  The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. , 1999, Stroke.

[12]  D. Sackett,et al.  Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. , 1998, The New England journal of medicine.

[13]  H. G. Beebe,et al.  Scientific evidence demonstrating the safety of carotid angioplasty and stenting: do we have enough to draw conclusions yet? , 1998, Journal of vascular surgery.

[14]  R. Tempelhoff,et al.  Anesthesia for Carotid Endarterectomy: A Survey , 1997, Journal of neurosurgical anesthesiology.

[15]  E. Mascha,et al.  Early outcome assessment for 2228 consecutive carotid endarterectomy procedures: the Cleveland Clinic experience from 1989 to 1995. , 1997, Journal of Vascular Surgery.

[16]  L. Fontenelle,et al.  Cranial/cervical nerve dysfunction after carotid endarterectomy. , 1997, Journal of vascular surgery.

[17]  G. Roubin,et al.  Angioplasty and stenting for restenosis after carotid endarterectomy. Initial experience. , 1996, Stroke.

[18]  D. Reid,et al.  Percutaneous Techniques for Endoluminal Carotid Interventions , 1996, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.

[19]  R. Kachel.  Results of Balloon Angioplasty in the Carotid Arteries , 1996, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.

[20]  Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. , 1995, JAMA.

[21]  W S Moore,et al.  Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. , 1993, The New England journal of medicine.

[22]  G. Moneta,et al.  Correlation of North American Symptomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis with duplex scanning. , 1993, Journal of vascular surgery.

[23]  G W PICKERING,et al.  Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. , 1954, Lancet.